1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. PTEN
  4. PTEN Modulator

PTEN Modulator

PTEN Modulator (1):

Cat. No. Product Name Effect Purity
  • HY-181097
    EGFR-IN-192
    Modulator
    EGFR-IN-192 is an anticancer agent. EGFR-IN-192 inhibits EGFR (IC50: 0.12 μM), downregulates the HIF-VEGF and PI3K/AKT/mTOR pathways, upregulates the tumor suppressor gene PTEN, and induces cell cycle arrest and apoptosis in tumor cells. EGFR-IN-192 exhibits antitumor activity and can be used in tumor research.